Acerus Pharmaceuticals Corporation (ASP.TO)

Equity · Currency in CAD · Last updated Jun 25, 2022

Company Info

ISIN	CA00444G4051
CUSIP	00444G405
Sector	Healthcare
Industry	Drug Manufacturers—Specialty & Generic

ASP.TOShare Price Chart

Click Calculate to get results

Benchmark

ASP.TOPerformance

The chart shows the growth of CA$10,000 invested in Acerus Pharmaceuticals Corporation on Aug 24, 2011 and compares it to the S&P 500 index or another benchmark. It would be worth nearly CA$90 for a total return of roughly -99.10%. All prices are adjusted for splits and dividends.

ASP.TO (Acerus Pharmaceuticals Corporation)

Benchmark (^GSPC)

ASP.TOReturns in periods

Returns over 1 year are annualized

Period	Return	Benchmark
1M	-43.04%	-0.75%
YTD	-62.50%	-19.93%
6M	-62.50%	-20.27%
1Y	-71.88%	-10.86%
5Y	-38.82%	6.71%
10Y	-41.13%	9.59%

ASP.TOMonthly Returns Heatmap

Click Calculate to get results

ASP.TOSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Acerus Pharmaceuticals Corporation Sharpe ratio is -0.48. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.

ASP.TO (Acerus Pharmaceuticals Corporation)

Benchmark (^GSPC)

ASP.TODividend History

Acerus Pharmaceuticals Corporation doesn't pay dividends

ASP.TODrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.

ASP.TO (Acerus Pharmaceuticals Corporation)

Benchmark (^GSPC)

ASP.TOWorst Drawdowns

The table below shows the maximum drawdowns of the Acerus Pharmaceuticals Corporation. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Acerus Pharmaceuticals Corporation is 99.75%, recorded on Jun 24, 2022. The portfolio has not recovered from it yet.

Depth	Start	To Bottom	Bottom	To Recover	End	Total
-99.75%	Apr 16, 2012	2559	Jun 24, 2022	—	—	—
-20%	Oct 3, 2011	3	Oct 5, 2011	3	Oct 11, 2011	6
-18.82%	Dec 2, 2011	13	Dec 20, 2011	31	Feb 6, 2012	44
-15.67%	Feb 17, 2012	7	Feb 28, 2012	30	Apr 11, 2012	37
-15.2%	Aug 25, 2011	13	Sep 13, 2011	6	Sep 21, 2011	19
-9.43%	Nov 22, 2011	2	Nov 23, 2011	2	Nov 25, 2011	4
-8.7%	Feb 10, 2012	1	Feb 10, 2012	1	Feb 13, 2012	2
-6.15%	Sep 23, 2011	4	Sep 28, 2011	2	Sep 30, 2011	6
-5.84%	Oct 13, 2011	8	Oct 24, 2011	1	Oct 25, 2011	9
-5.06%	Nov 2, 2011	1	Nov 2, 2011	3	Nov 7, 2011	4

ASP.TOVolatility Chart

Current Acerus Pharmaceuticals Corporation volatility is 154.44%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.

ASP.TO (Acerus Pharmaceuticals Corporation)

Benchmark (^GSPC)

Portfolios with Acerus Pharmaceuticals Corporation

Loading data...